Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Sanidad Militar
versión impresa ISSN 1887-8571
Resumen
SANCHEZ JIMENEZ, FJ; LOPEZ HONDUVILLA, FJ; APARICIO HERNANDEZ, R y GARCIA LUQUE, A. Possitive assessment of drugs: june/july 2017. Sanid. Mil. [online]. 2017, vol.73, n.4, pp.226-230. ISSN 1887-8571. https://dx.doi.org/10.4321/s1887-85712017000400005.
The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in, June1 and July 20172, considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.
Palabras clave : Adalimumab (Imraldi®); Atezolizumab (Tecentriq®); Avelumab (Bavencio®); Ciclosporina (Verkazia®); Cladribina (Mavenclad®): Darunavir/Cobicistat/Emtricitabina/ Tenofovir Alafenamida (Symtuza®); Dupilumab (Dupixent®); Glecaprevir/Pibrentasvir (Maviret®): Lutecio (177lu) Oxodotreotido (Lutathera®); Midostaurina (Rydapt®); Ribociclib (Kisqal®); Sofosbuvir/Velpatasvir/ Voxilaprevir (Vosevi®); Telotristat de Etilo (Xermelo®); Tivozanib Hidrocloruro Monohidrato (Fotivda®).